Results 101 to 110 of about 29,391 (178)

Nanobody mediated inhibition of attachment of F18 fimbriae expressing Escherichia coli [PDF]

open access: yes, 2014
Post-weaning diarrhea and edema disease caused by F18 fimbriated E. coli are important diseases in newly weaned piglets and lead to severe production losses in farming industry.
Coddens, Annelies   +6 more
core   +4 more sources

Identification and pathogenomic analysis of an Escherichia coli strain producing a novel Shiga toxin 2 subtype

open access: yesScientific Reports, 2018
Shiga toxin (Stx) is the key virulent factor in Shiga toxin-producing Escherichia coli (STEC). To date, three Stx1 subtypes and seven Stx2 subtypes have been described in E. coli, which differed in receptor preference and toxin potency.
Xiangning Bai   +8 more
doaj   +1 more source

Transmission and quantification of verocytotoxin-producing Escherichia coli O157 in dairy cattle and calves [PDF]

open access: yes
Data from a field study of 14 months duration in a naturally colonized dairy herd and data from an experiment with calves were used to quantify transmission of verocytotoxin-producing Escherichia coli (VTEC O157) in cattle.
Frankena, K.   +4 more
core   +2 more sources

Consensus report: E. coli O104:H4 (HUSEC041) and the potential threat to European water supplies. [PDF]

open access: yes, 2011
Among the 3rd Seminar for PhD students working on Water and Health which was held in Cannes on 27–29 June 2011, experts from a number of universities and research institutes took the opportunity to discuss the emergence of Escherichia coli O104:H4 in ...
Exner, Martin   +7 more
core  

Tamoxifen blocks retrograde trafficking of Shiga toxin 1 and 2 and protects against lethal toxicosis

open access: yesLife Science Alliance, 2019
This study reports an unexpected role of late endosome–lysosome fusion in early endosome-to-Golgi trafficking of Shiga toxins and identifies tamoxifen to be a potent inhibitor of Shiga toxicosis. Shiga toxin 1 (STx1) and 2 (STx2), produced by Shiga toxin–
Andrey S Selyunin   +3 more
doaj   +1 more source

Isolation of Shiga toxin-producing Escherichia coli from raw milk in Kermanshah, Iran

open access: yesIranian Journal of Microbiology, 2013
Background and Objectives: Infectious diarrhoeal diseases are great problem throughout the world and are responsible for considerable morbidity and mortality.
Pantea Mohammadi   +3 more
doaj  

Aplikasi Kandidat Pemindai untuk Diagnosis Gen Shiga like toxin-2 dari Escherichia coli O157:H7 (PROBE APLICATION TO DIAGNOSTIC PROGRAME OF SHIGA LIKE TOXIN-2 (STX2) GEN FROM ESCHERICHIA COLI O157:H7)

open access: yesJurnal Veteriner, 2013
A Shiga-like toxin producing Escherichia coli O157:H7 has been detected in cattle fecal sample, atbeef, and human as well as in beef and indicating that the agent is a harmful zoonosis bacteria. Geneticanalysis of Shiga toxin Escherichia coli (STEC) gene
I Wayan Suardana   +2 more
doaj  

Shiga Toxin–producing Escherichia coli, Idaho

open access: yesEmerging Infectious Diseases, 2007
Vivian Marie Lockary   +2 more
doaj   +1 more source

Primary Thrombotic Microangiopathy in Pediatric Patients

open access: yesGlobal Pediatric Health
Background . Primary thrombotic microangiopathy includes hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli , atypical hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura. Methodology .
Andrés David Aranzazu Ceballos MD   +5 more
doaj   +1 more source

National Enteric Disease Surveillance : Shiga toxin-producing Escherichia coli (STEC) annual report, 2015 [PDF]

open access: yes
The Laboratory-based Enteric Disease Surveillance (LEDS) system contributes to the understanding of human Shiga toxin-producing Escherichia coli (STEC) in the United States by collecting reports of infections submitted by state and regional public health

core  

Home - About - Disclaimer - Privacy